Contract HHSD2002010M37479P
Biogx, Inc · Department Of Health And Human Services · September 27, 2010
Biogx, Inc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on September 27, 2010 for $97,000 of work in pharmaceutical preparation manufacturing. Performance is in Atlanta, GA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 24, 2013.
Contract details
- PIID
- HHSD2002010M37479P
- Award type
- Po
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Atlanta, GA
- First action
- September 27, 2010
- Latest action
- September 24, 2013
Description
CUSTOM BEADS
Modification timeline
-
September 24, 2013Mod 2$0
-
October 13, 2010Mod 1$0
-
September 27, 2010Base awardTAS::75 0943::TAS 000HCVH1-2010-91437 - CEPHEID GENEXPERT PLATFORM CONVERSION$97.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD2002010M37479P?
Contract HHSD2002010M37479P is a federal contract awarded to Biogx, Inc by Department Of Health And Human Services on September 27, 2010 for $97,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract HHSD2002010M37479P?
Biogx, Inc won contract HHSD2002010M37479P from Department Of Health And Human Services.
How much is contract HHSD2002010M37479P worth?
Contract HHSD2002010M37479P has obligated $97,000 to date.